SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Abeona Therapeutics Q3 EPS $(0.35) Down From $(0.34) YoY; Cash And Cash Equivalents As Of Sept. 30 $47.9M

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.

Benzinga · -

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.